Ossiam’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.31M | Sell |
26,613
-1,003
| -4% | -$96.1K | 0.04% | 151 |
|
|
2025
Q4 | $2.65M | Buy |
27,616
+2,929
| +12% | +$285K | 0.05% | 140 |
|
|
2025
Q3 | $2.35M | Sell |
24,687
-1,986
| -7% | -$183K | 0.03% | 314 |
|
|
2025
Q2 | $2.33M | Sell |
26,673
-7,981
| -23% | -$677K | 0.03% | 256 |
|
|
2025
Q1 | $3.11M | Buy |
34,654
+1,085
| +3% | +$97.1K | 0.04% | 178 |
|
|
2024
Q4 | $2.68M | Buy |
33,569
+253
| +0.8% | +$21.9K | 0.05% | 204 |
|
|
2024
Q3 | $3M | Sell |
33,316
-2,150
| -6% | -$181K | 0.06% | 157 |
|
|
2024
Q2 | $2.79M | Buy |
35,466
+302
| +0.9% | +$24.8K | 0.05% | 170 |
|
|
2024
Q1 | $3.06M | Buy |
35,164
+1,863
| +6% | +$159K | 0.05% | 191 |
|
|
2023
Q4 | $2.74M | Sell |
33,301
-12,459
| -27% | -$950K | 0.04% | 179 |
|
|
2023
Q3 | $3.59M | Buy |
45,760
+17,036
| +59% | +$1.43M | 0.06% | 138 |
|
|
2023
Q2 | $2.53M | Buy |
28,724
+16,932
| +144% | +$1.46M | 0.05% | 189 |
|
|
2023
Q1 | $951K | Buy |
11,792
+3,745
| +47% | +$305K | 0.02% | 287 |
|
|
2022
Q4 | $625K | Sell |
8,047
-8,488
| -51% | -$688K | 0.02% | 340 |
|
|
2022
Q3 | $1.33M | Buy |
16,535
+16,365
| +9,626% | +$1.47M | 0.04% | 228 |
|
|
2022
Q2 | $15K | Sell |
170
-9,522
| -98% | -$965K | ﹤0.01% | 404 |
|
|
2022
Q1 | $1.07M | Buy |
9,692
+2,499
| +35% | +$264K | 0.03% | 217 |
|
|
2021
Q4 | $744K | Sell |
7,193
-8,420
| -54% | -$975K | 0.02% | 265 |
|
|
2021
Q3 | $1.96M | Buy |
15,613
+11,660
| +295% | +$1.51M | 0.06% | 185 |
|
|
2021
Q2 | $519K | Sell |
3,953
-4,296
| -52% | -$539K | 0.01% | 318 |
|
|
2021
Q1 | $974K | Buy |
8,249
+7,545
| +1,072% | +$884K | 0.03% | 225 |
|
|
2020
Q4 | $82K | Buy |
704
+539
| +327% | +$59.3K | ﹤0.01% | 366 |
|
|
2020
Q3 | $17K | Sell |
165
-3,983
| -96% | -$400K | ﹤0.01% | 377 |
|
|
2020
Q2 | $380K | Sell |
4,148
-10,191
| -71% | -$977K | 0.02% | 266 |
|
|
2020
Q1 | $1.29M | Sell |
14,339
-26,681
| -65% | -$2.84M | 0.09% | 157 |
|
|
2019
Q4 | $4.65M | Sell |
41,020
-52,301
| -56% | -$5.74M | 0.35% | 60 |
|
|
2019
Q3 | $10.1M | Buy |
93,321
+89,204
| +2,167% | +$9.31M | 0.71% | 33 |
|
|
2019
Q2 | $401K | Sell |
4,117
-8,559
| -68% | -$781K | 0.03% | 249 |
|
|
2019
Q1 | $1.16M | Sell |
12,676
-29,998
| -70% | -$2.68M | 0.1% | 128 |
|
|
2018
Q4 | $3.88M | Buy |
+42,674
| New | +$3.99M | 0.58% | 56 |
|
Other funds holding MDT
VCM
VPM
Ossiam's MDT Position: Q1 2026 in Review
Ossiam reduced its Medtronic (MDT) stake by 3.6% in Q1 2026, selling an estimated $96.1K and leaving 26,613 shares worth $2.31M. The position accounts for 0.04% of the portfolio, ranked #151.
Ossiam first reported a position in MDT in Q4 2018 and has held it in 30 quarters since. The position peaked at $10.1M in Q3 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Ossiam held 26,613 shares of Medtronic worth $2.31M as of Q1 2026.
- Ossiam sold 1,003 Medtronic shares in Q1 2026, an estimated $96.1K.
- Medtronic made up 0.04% of Ossiam's portfolio in Q1 2026, its #151 holding.
- Ossiam first reported a position in Medtronic in Q4 2018 and has held it in 30 quarters since.
- Ossiam's Medtronic position peaked at $10.1M in Q3 2019.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Ossiam's 13F filing for Q1 2026, filed 14 May 2026.